Search results for: 'post development'

22 Aug 2022  |  North America  |  Frost Radar

Frost Radar™ for Economic Development: The United States, 2022

Texas, California and Georgia Emerge as Top States for Demonstrating Strong Investment Potential

Infographics

×

Key Issues Addressed

The Frost Radar™ for Economic Development for the United States determines the investment potential for each state measured by favorable state policies that will effectively drive inward investment and that are driven by social factors. This report explores key strengths and weaknesses of the the US economy through state-level assessments of growt...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

As the post-COVID-19 scenario looms, traditional business models are undergoing rapid changes, and the need to innovate and expand the business model portfolio becomes essential to enable enterprise survival and growth. Multiple trends are driving the need for business model innovation, such as supply chains undergoing pandemic-induced transformati...

09 Jul 2020  |  North America  |  Market Research

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Infographics

×

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

27 Oct 2021  |  North America  |  Frost Radar

Frost Radar™ for Economic Development: Americas, 2021

Canada, United States, and Chile Emerge as the American Leaders

Infographics

×

Key Issues Addressed

The Frost Radar for Economic Development determines a region's future growth and development potential measured by its ability to enhance the quality of life (QOL) for its citizens. This report explores the Americas' key strengths and weaknesses through country-level assessments of growth and innovation initiatives and then benchmarks each country ...